⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy

Official Title: Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy : HYDRA Study

Study ID: NCT04657120

Interventions

YEARS algorithm
CTPA

Study Description

Brief Summary: The aim of this study is to prospectively validate the safety and efficiency of management according to the YEARS algorithm to safely rule out clinically suspected PE in patients with active malignancy to be compared with 'standard' management by computed tomography pulmonary angiography (CTPA) alone in a randomized study.

Detailed Description: Recently, the YEARS-algorithm was demonstrated to be a safe and efficient diagnostic strategy for patients with clinically suspected pulmonary embolism (PE). It is recognized that diagnostic algorithms for pulmonary embolism (PE) may not be as effective and safe in patients with malignancy, due to the low specificity of D-dimer test in that setting. A diagnostic algorithm that could safely rule out PE in patients with malignancy without performing computed tomography pulmonary angiography (CTPA) could nonetheless improve patient care.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Antwerpen University Hospital (UZA), Antwerpen, , Belgium

Cliniques Universitaires Saint-Luc (CUSL), Bruxelles, , Belgium

Centre Hospitalier Universitaire de Liège (CHU Liège), Liège, , Belgium

CHU Brest, Brest, , France

CHU Clermont-Ferrand, Clermont-Ferrand, , France

Hôpital Louis Mourier - APHP, Colombes, , France

HEGP, Paris, , France

CHU Saint-Etienne, Saint-Étienne, , France

Policlinico di Milano Ospedale Maggiore | Fondazione IRCCS Ca' Granda, Milan, , Italy

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, , Italy

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, , Netherlands

Flevoziekenhuis, Almere, , Netherlands

Amsterdam UMC, Amsterdam, , Netherlands

Rijnstate Ziekenhuis, Arnhem, , Netherlands

Amphia Ziekenhuis, Breda, , Netherlands

Reinier de Graaf Gasthuis, Delft, , Netherlands

Groene Hart Ziekenhuis, Gouda, , Netherlands

Tergooi MC, Hilversum, , Netherlands

Leiden University Medical Center, Leiden, , Netherlands

Radboud UMC, Nijmegen, , Netherlands

Maasstad Ziekenhuis, Rotterdam, , Netherlands

Haaglanden Medisch Centrum, The Hague, , Netherlands

Bernhoven Ziekenhuis, Uden, , Netherlands

Diakonessenhuis, Utrecht, , Netherlands

Hospital Universitario Ramón y Cajal, Madrid, , Spain

The Inselspital Bern, Bern, , Switzerland

Hôpitaux Universitaires de Genève (HUG), Geneva, , Switzerland

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, , Switzerland

Contact Details

Name: Emily MARTENS, MD

Affiliation: Leiden University Medical Center

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: